Understand the source comparison
Peptides for Joint Pain Research: Compound Comparison
The following table compares peptides under active investigation for joint pain research applications based on mechanism, target pathways, preclinical evidence, and study model relevance. BPC-157 Angiogenesis, collagen deposition, cytokine modulation VEGF, FGF
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The following table compares peptides under active investigation for joint pain research applications based on mechanism, target pathways, preclinical evidence, and study model relevance.
- BPC-157
- Angiogenesis, collagen deposition, cytokine modulation
- VEGF, FGF, FAK-paxillin
- Moderate. Multiple rodent studies, no human RCTs
- Tendon injury, ligament repair, cartilage preservation
- Best-documented compound for soft tissue repair; reproducible effects across injury types but lacks human validation
- TB-500 (Thymosin Beta-4)
- Actin sequestration, cell migration, anti-inflammatory
- G-actin binding, IL-6/IL-8 downregulation
- Moderate. Consistent rodent data, Phase I human safety only
- Ligament injury, wound healing, post-surgical repair
- Strong mechanistic rationale; effects most pronounced in acute inflammatory phase; limited data on chronic joint pathology
- Ipamorelin
- Growth hormone secretion, systemic IGF-1 elevation
- GHSR-1a receptor, IGF-1R activation
- Moderate. Aging models show cartilage preservation effects
- Osteoarthritis models, cartilage degradation prevention
- Indirect mechanism (via IGF-1); requires sustained administration; dose-response plateaus above threshold
- CJC-1295
- Sustained growth hormone release, IGF-1 elevation
- GHRH receptor, prolonged half-life via DAC
- Moderate. Similar to Ipamorelin, systemic effects only
- Aging/degenerative models, cartilage thickness preservation
- Longer half-life than Ipamorelin; similar IGF-1-mediated effects; no evidence of superior joint outcomes vs other GH secretagogues
- GHK-Cu
- Collagen synthesis, MMP modulation, antioxidant
- Copper-dependent collagen cross-linking, MMP inhibition
- Low. In vitro data strong, limited in vivo joint-specific studies
- Cartilage repair, ECM remodeling
- Promising in vitro fibroblast studies; lacks robust animal model validation for joint applications